YaşarEBayramoğluAKarakuşYÇakmakT. The CHA2DS2-VASc risk score predicts total occlusion in infarct-related arteries in patients with non-ST elevation myocardial infarction. Angiology2021. DOI: 10.1177/00033197211031324.
2.
JanuaryCTWannLSAlpertJS, et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol2014; 64: 1-76.
3.
LipGYNieuwlaatRPistersRLaneDACrijnsHJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest2010; 137: 263-72.
4.
KurtulAAcikgozSK. Validation of the CHA2DS2-VASc score in predicting coronary atherosclerotic burden and In-hospital mortality in patients with acute coronary syndrome. Am J Cardiol2017; 120: 8-14.
5.
KurtulAYarliogluesMDuranM. Predictive value of CHA2DS2-VASC score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol2017; 119: 819-825.
6.
MirboloukFGholipourMSalariA, et al.CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res2018; 10: 46-52.
7.
KurtulA. Usefulness of the CHA2DS2-VASc score in predicting in-stent restenosis among patients undergoing revascularization with bare-metal stents. Clin Appl Thromb Hemost2018; 24: 589-95.
8.
TanıkVOAruğaslanEÇinarTKeskinMKayaATekkeşinAI. Association of the CHA2DS2VASc score with acute stent thrombosis in patients with an ST elevation myocardial infarction who underwent a primary percutaneous coronary intervention. Med Princ Pract2019; 28: 115-23.
9.
WęgielMRakowskiTDziewierzA, et al.CHA2DS2-VASc and R2-CHA2DS2-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction. Postepy Kardiol Interwencyjnej2018; 14: 391-8.
10.
ModiRPattedSVHalkatiPC, et al.CHA2DS2-VASc-HSF score-New predictor of severity of coronary artery disease in 2976 patients. Int J Cardiol2017; 228: 1002-6.
11.
AndriantoAJovieBAl-FarabiMJGandiPShonafiKALathifahR. Novel CHA2DS2-VASc-HSF is Superior to CHADS2 and CHA2DS2-VAScScore to predict the risk of severe coronary artery disease. Macedonian J Med Sci2020; 8: 451-6.
12.
ZhangQYMaSMSunJY. New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord2020; 20: 346.
13.
KalyoncuoğluMDurmuşGBelenECanMM. Predictive accuracy of the CHA2DS2-VASc-HSF score in determining one-year cardiovascular outcomes in patients with non-ST-elevation acute coronary syndrome: A retrospective study. Koşuyolu Heart J2020; 23: 27-37.
